Cryomass Technologies Inc Form 8-K: Current report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-08-04: Form 8-K; Period of report 2025-08-04; Description 8.01 Other Events; Details 8.01.
- 2025-05-08: Form 8-K; Period of report 2025-05-02; Description 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; Details 1.01.
- 2025-02-26: Form 8-K; Period of report 2025-02-26; Description 7.01 Regulation FD Disclosure; Details 7.01.
- 2024-05-16: Form 8-K; Period of report 2024-05-16; Description 7.01 Regulation FD Disclosure; Details 7.01.
| Filed | Form | Period of report | Description | Details | Document |
|---|---|---|---|---|---|
| 2025-08-04 | 8-K | 2025-08-04 | 8.01 Other Events | 8.01 As of August 4, 2025, Cryomass Technologies Inc, a Nevada corporation (the “Company”) wishes to inform its shareholders that OTC Markets Group moved the Company’s trading from OTC Pink to the Expert Market due to the Company not being current with its regulatory filings. | ea0251713-8k_cryomass.htm |
| 2025-05-08 | 8-K | 2025-05-02 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 On May 2, 2025 Cyomass Technologies Inc (the “Company”) entered into a subscription agreement with a domestic accredited investor (“Subscription Agreement”), a form of which is attached hereto and incorporated by reference, pursuant to which the Company issued and sold to an accredited investor, in the initial tranche of a non-brokered private placement (the “Private Placement”), 17,777,778 Units (“Units”), each Unit representing (1) 1 Common Stock purchase warrant exercisable to purchase one share of the Corporation’s common stock per Warrant (each such share a “Warrant Share”) at an exercise price of US$0.03375 per Warrant Share (the “Warrant”), substantially in the form attached to the Subscription Agreement as Appendix C, and (2) 1 Pre-Funded Common Stock purchase warrant exercisable to purchase one Warrant Share at an exercise price of US$0.0001 per Warrant Share (the “PFW”), substantially in the form attached to the Subscription Agreement as Appendix E for net proceeds of US$400,000. 3.02 The information set forth in Item 1.01 of this Current Report on Form 8-K concerning the offer and sale of the shares of Units pursuant to the Subscription Agreement is incorporated herein by reference. | ea0241225-8k_cryomass.htm |
| 2025-02-26 | 8-K | 2025-02-26 | 7.01 Regulation FD Disclosure | 7.01 On February 26, 2025, CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea0232251-8k_cryomass.htm |
| 2024-05-16 | 8-K | 2024-05-16 | 7.01 Regulation FD Disclosure | 7.01 On May 16, 2024, CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea020637301-8k_cryomass.htm |
| 2024-05-14 | 8-K | 2024-05-14 | 7.01 Regulation FD Disclosure | 7.01 On May 14, 2024, CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea0206065-8k_cryomass.htm |
| 2024-02-06 | 8-K | 2024-02-05 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 5, 2024, the Audit Committee (the “Audit Committee”) of the Board of Directors of Cryomass Technologies Inc, a Nevada corporation (the “Company”), unanimously approved the engagement of Haynie & Company (“Haynie”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2024, effective immediately. | ea192965-8k_cryomass.htm |
| 2024-01-29 | 8-K | 2024-01-29 | 7.01 Regulation FD Disclosure | 7.01 On January 29, 2024, CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea192354-8k_cryomass.htm |
| 2024-01-16 | 8-K | 2024-01-09 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | ea191670-8k_cryomass.htm |
| 2023-12-22 | 8-K | 2023-12-20 | 1.02 Termination of a Material Definitive Agreement | 1.02 As previously disclosed, on August 15, 2023, Cryomass Technologies Inc (the “Company”), on one side, and RedTape Core Partners LLC and Coastal Refinement Solutions Inc (collectively, “RedTape”) on the other side, entered into an Amended and Restated Patent License and Equipment Rental Agreement (the “Agreement”). | ea190615-8k_cryomass.htm |
| 2023-12-07 | 8-K | 2023-12-05 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On December 5, 2023, Cryomass Technologies Inc (‘Company”) received formal notice that the Company’s independent auditors, Macias Gini & O’Connell LLP (“MGO”) had made the decision to resign as Company’s independent accountants effective December 5, 2023. | ea189680-8k_cryomass.htm |
| 2023-08-31 | 8-K | 2023-08-31 | 7.01 Regulation FD Disclosure | 7.01 On August 31, 2023 CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea184532-8k_cryomass.htm |
| 2023-07-14 | 8-K | 2023-07-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On July 13, 2023 the Board of Directors of CryoMass Technologies Inc (‘Company”) (‘Board”) adopted a unanimous Board consent in lieu of a meeting, amending the employment agreements of two company officers, Mr. Philip Blair Mullin, Chief Financial Officer, and Ms. Patricia Kovacevic, General Counsel Corporate Secretary and Head of External Affairs. | ea181796-8k_cryomass.htm |
| 2023-07-07 | 8-K | 2023-07-07 | 7.01 Regulation FD Disclosure | 7.01 On July 7, 2023 CryoMass Technologies Inc (‘Company”) issued a press release (“Press Release”), which was also disseminated on the same day via email to certain shareholders who provided contact information. | ea181482-8k_cryomass.htm |
| 2023-06-12 | 8-K | 2023-06-12 | 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 7.01 On June 12, 2023, during the Annual Meeting of the Stockholders of the Company, the Chief Executive Officer of the Company, Mr. Christian Noël, provided verbal remarks. | ea180195-8k_cryomass.htm |
| 2023-04-04 | 8-K | 2023-04-03 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On April 3, 2023, the Audit Committee (the “Audit Committee”) of the Board of Directors of Cryomass Technologies Inc, a Nevada corporation (the “Company”), approved the engagement of Macias Gini & O’Connel LLP (“MGO”) as the Company’s independent registered public accounting firm for the Company’s fiscal year ending December 31, 2023, effective immediately, and resolved to terminate BF Borgers CPA PC (“Borgers”) as the Company's independent registered public accounting firm, effective immediately. | ea176409-8k_cryomass.htm |
| 2023-01-18 | 8-K | 2023-01-16 | 1.01 Entry into a Material Definitive Agreement; 7.01 Regulation FD Disclosure | 1.01 On January 16, 2023, Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”, also termed “Licensor”) entered into a Patent License and Equipment Rental Agreement (“License Agreement”) with RedTape Core Partners LLC and its affiliates (collectively, “Licensee”) and Coastal Refinement Solutions Inc (“First Sublicensee”), effective on the same date (“Effective Date”). 7.01 On January 18, 2023, the Company issued a press release, a copy of which is furnished as Exhibit 99.1 to this report and incorporated herein by reference. | ea171830-8k_cryomass.htm |
| 2022-12-07 | 8-K | 2022-12-02 | 8.01 Other Events | 8.01 On December 2, 2022, Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”) board resolved that the 2023 Annual Meeting of Stockholders of the Company shall take place on June 12, 2023 beginning with 10AM MDT at the offices of the Company and via electronic teleconference, or other electronic means, or such other time and date as the Officers of the Company, in their sole discretion, may determine appropriate and decide. | ea169796-8k_cryomass.htm |
| 2022-09-09 | 8-K | 2022-09-08 | 7.01 Regulation FD Disclosure | 7.01 On September 8, 2022, Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”) issued an investor communication via email, linking to an investor presentation, a copy of each being furnished as Exhibit 99.1 and Exhibit 99.2, respectively, to this report and incorporated herein by reference. | ea165579-8k_cryomass.htm |
| 2022-08-09 | 8-K | 2022-08-09 | 7.01 Regulation FD Disclosure | 7.01 On August 9, 2022, Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”) issued a press release, a copy of which is furnished as Exhibit 99.1 to this report and incorporated herein by reference. | ea164054-8k_cryomass.htm |
| 2022-08-04 | 8-K | 2022-08-04 | 7.01 Regulation FD Disclosure | 7.01 On August 4, 2022, Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”) issued a press release, a copy of which is furnished as Exhibit 99.1 to this report and incorporated herein by reference. | ea163832-8k_cryomasstech.htm |
| 2022-07-12 | 8-K | 2022-07-12 | 7.01 Regulation FD Disclosure | 7.01 On July 12, 2022, OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets, announced that Cryomass Technologies Inc (OTCQX: CRYM) (the “Company”) has qualified to trade on the OTCQX® Best Market, upgrading to OTCQX from the OTCQB® Venture Market.. | ea162742-8k_cryomass.htm |
| 2022-06-21 | 8-K | 2022-06-20 | 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 5.07 On June 20, 2022, Cryomass Technologies Inc (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). 7.01 On June 20, 2022, during the Annual Meeting of the Stockholders of the Company, the Chief Executive Officer of the Company, Mr. Christian Noël, provided verbal remarks. | ea161816-8k_cryomass.htm |
| 2022-05-31 | 8-K | 2022-05-31 | 7.01 Regulation FD Disclosure | 7.01 On May 31, 2022, the Company issued a press release regarding a recent patent grant in Canada. | ea160841-8k_cryomass.htm |
| 2022-05-02 | 8-K | 2022-05-02 | 7.01 Regulation FD Disclosure | ea159211-8k_cryomass.htm | |
| 2022-01-18 | 8-K | 2022-01-17 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure | 7.01 On January 18, 2022, the Company issued a press release regarding Mr. Simon Langelier’s appointment to the Board of Directors of the Company. | ea154092-8k_cryomass.htm |
| 2022-01-10 | 8-K | 2022-01-10 | 5.07 Submission of Matters to a Vote of Security Holders; 7.01 Regulation FD Disclosure | 5.07 On January 10, 2022, Cryomass Technologies Inc (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). 7.01 On January 10, 2022, during the Annual Meeting of the Stockholders of the Company, the Chief Executive Officer of the Company, Mr. Christian Noël, provided verbal remarks. | ea153790-8k_cryomasstech.htm |
| 2021-12-06 | 8-K | 2021-12-06 | 7.01 Regulation FD Disclosure | 7.01 On December 6, 2021, the Company issued a press release providing a business update. | ea151790-8k_cryomasstech.htm |
| 2021-11-19 | 8-K | 2021-09-16 | 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities | 1.01 Entry into a Material Definitive Agreement. 3.02 The information set forth in Item 1.01 above regarding the Private Placement is incorporated herein by reference. | ea151076-8k_cryomass.htm |
| 2021-09-14 | 8-K/A | 2021-06-22 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 This Amendment No.1 on Form 8-K/A (“Form 8-K/A”) amends the Current Report on Form 8-K filed by Cryomass Technologies Inc. (formally known as Andina Gold Corp., the “Company”) with the Securities and Exchange Commission (“SEC”) on June 28, 2021 (the “June Form 8-K”). | ea147235-8ka1_cryomass.htm |
| 2021-08-27 | 8-K | 2021-08-27 | 7.01 Regulation FD Disclosure | 7.01 On August 27, 2021, the Company issued a press release announcing that the name of the Company changed from Andina Gold Corp to Cryomass Technologies Inc effective August 27, 2021. | ea146571-8k_cryomasstech.htm |
| 2021-07-27 | 8-K | 2021-07-23 | 1.01 Entry into a Material Definitive Agreement; 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 1.01 Entry into a Material Definitive Agreement. 5.03 On July 26, 2021 we filed articles of merger, or the Articles of Merger, with the Secretary of State of the state of Nevada to effect the Merger. | ea144867-8k_andinagold.htm |
| 2021-07-26 | 8-K | 2021-07-26 | 7.01 Regulation FD Disclosure | 7.01 On July 26, 2021, the Company issued a press release announcing future corporate rebranding and an update on product design. | ea144775-8k_andinagold.htm |
| 2021-07-13 | 8-K | 2021-07-13 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 (a) Appointment of Certain Officers. | ea144142-8k_andinagold.htm |
| 2021-07-07 | 8-K | 2021-03-29 | 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure | 3.02 Between March 29, 2021 and July 6, 2021, Andina Gold Corp. (the “Company”) entered into a series of substantially similar subscription agreements with either domestic or non-US accredited investors, respectively (each, a “Initial Tranche Subscription Agreement (US)” and, respectively, “Initial Tranche Subscription Agreement (non-US)”) pursuant to which the Company issued and sold to certain accredited investors, in the initial tranche of a non-brokered private placement (the “Private Placement”), an aggregate 3,000 units (“Units”), each Unit representing (i) one $1,000 principal amount term note providing for an optional conversion into shares of Company common stock at a price of $0.20 per share (each the “Initial Convertible Term Note”) and (ii) a common share warrant for the purchase of 5,000 shares of Company common stock at an exercise price of $0.40 per share (each an “Initial Warrant”), for aggregate net proceeds of US$3,000,000. 7.01 On July 7, 2021, the Company issued a press release announcing the completion of the Private Placement, a copy of which is furnished as Exhibit 99.1 to this report and incorporated herein by reference. | ea143876-8k_andinagold.htm |
| 2021-06-28 | 8-K | 2021-06-22 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets; 7.01 Regulation FD Disclosure | 1.01 Entry into a Material Definitive Agreement. 2.01 The information regarding the Purchase Agreement and the Acquisition set forth in Item 1.01 is incorporated herein by reference. 7.01 On June 28, 2021, the Company issued a press release announcing the execution of the Purchase Agreement, a copy of which is furnished as Exhibit 99.1. | ea143398-8k_andinagold.htm |
| 2021-05-19 | 8-K | 2021-05-13 | 1.01 Entry into a Material Definitive Agreement | 1.01 Entry into a Material Definitive Agreement. | ea141346-8k_andinagold.htm |
| 2021-04-01 | 8-K | 2021-03-29 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 On March 31, 2021 the employment agreement between the Company and its current Chief Executive Officer expired and it was not renewed or extended. | ea138802_8k-andinagold.htm |
| 2021-03-22 | 8-K | 2021-03-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of March 21, 2021, Gary Joseph Artmont has resigned as a director of the Company Mr. Arrmont’s resignation was not a result of any disagreements with the Company. | ea138166_8k-andinagold.htm |
| 2021-03-04 | 8-K | 2021-02-26 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 Effective as of February 26, 2021, Carlos Andrés Hernández Nuñez has resigned as a director of the Company Mr. Hernandez Nuñez’s resignation was not a result of any disagreements with the Company. 8.01 On February 25, 2021 the Company entered into a non-binding letter of intent (“LOI”) with CryoCann USA Corporation (“CryoCann”), a California company headquartered in Santa Ana, California, for a proposed asset purchase transaction (the “Proposed Transaction”). | ea137034-8k_andinagold.htm |
| 2021-03-04 | 8-K | 2021-02-26 | 8.01 Other Events | 8.01 On February 26, 2021 the Company received from the Colorado Department of Revenue, State Licensing Authority, a Notice of Denial in the matter of suitability for Owner-Entity applications for the Company and its wholly owned subsidiary, Good Meds, Inc. The Department of Revenue advised the Company that, pursuant to subsection 24-4-104(9), C.R.S., the Company has the right to request in writing a hearing regarding the denial of the Company’s applications within 60 days from the certified date of service of the Notice of Denial. | ea137032-8k_andinagold.htm |
| 2020-10-30 | 8-K | 2020-10-30 | 8.01 Other Events | 8.01 Incorporated by reference is a press release issued by the Company on October 30, 2020 and attached hereto as Exhibit 99. | ea129200-8k_andina.htm |
| 2020-10-22 | 8-K | 2020-10-21 | 8.01 Other Events | 8.01 On October 21, 2020, the Financial Industry Regulatory Authority (“FINRA”) announced the effectiveness of a change in the Company’s name from “Redwood Green Corp.” to “Andina Gold Corp.” (the “Name Change”) and a change in the Company’s ticker symbol from “RDGC” to the new trading symbol “AGOL” (the “Symbol Change”), which became effective on the opening of trading as of October 22, 2020. | ea128693-8k_andinagold.htm |
| 2020-09-03 | 8-K | 2020-09-02 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On August ___, 2020 our Board of Directors approved an agreement and plan of merger to merge with our wholly-owned subsidiary Andina Gold Corp. to effect the name change from Redwood Green Corp.to Andina Gold Corp. Our company will remain the surviving company. | ea126419-8k_andinacorp.htm |
| 2020-08-13 | 8-K | 2020-08-11 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of August 11, 2020, John Scharffenberger and Steven Hilton have each resigned as a director of the Company. | ea125505-8k_redwoodgreen.htm |
| 2020-07-21 | 8-K | 2020-07-20 | 1.01 Entry into a Material Definitive Agreement; 1.02 Termination of a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 1.02 The Company entered into a Separation and Consulting Agreement (the “Separation Agreement”) dated February 26, 2020, which was terminated through a Termination Agreement dated July 20, 2020. 5.02 Effective as of July 20, 2020, the Board elected Christopher A. Hansen as Chief Executive Officer. | ea124411-8k_redwood.htm |
| 2020-07-01 | 8-K | 2020-06-30 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of June 30, 2020, Michael Saxon resigned as CEO and a director of the Company by mutual agreement. | ea123721-8k_redwoodgreen.htm |
| 2020-06-25 | 8-K | 2020-06-23 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On June 23, 2020, the Board of Directors (the “Board”) of Redwood Green Corp. (the “Company”) amended and restated the Company’s Amended and Restated Bylaws, as amended (the “Bylaws”), effective immediately. | ea123470-8k_redwood.htm |
| 2020-05-26 | 8-K | 2020-05-06 | 8.01 Other Events | 8.01 Effective as of May 6, 2020 the consulting agreement between Redwood Green Corp. (the “Company”) and Anthony Wile was terminated by mutual agreement. | ea122301-8k_redwood.htm |
| 2020-04-22 | 8-K | 2020-04-22 | 7.01 Regulation FD Disclosure | 7.01 On April 22, 2020 Redwood Green Corp. (the “Company”), announced its intent to offer up to $3 million of shares of common stock (with a right to increase the size of the offering to $5 million) at a purchase price of $0.25 per share through a private placement (the “Offering”). | ea120941-8k_redwoodgreen.htm |
| 2020-04-22 | 8-K | 2020-04-21 | 7.01 Regulation FD Disclosure | 7.01 We are furnishing this Current Report on Form 8-K in connection with the disclosure of information, in the form of the textual information from a PowerPoint presentation to be given at meetings with institutional investors or existing shareholders. | ea120876-8k_redwood.htm |
| 2020-04-15 | 8-K | 2020-04-13 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of April 13, 2020, Patricia I. Kovacevic (age 49) joined the Company as General Counsel. | ea120725-f8k_redwoodgreen.htm |
| 2020-04-13 | 8-K | 2020-04-06 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of April 6, 2020, Christopher Hansen resigned as a director of the Company. | ea120623-f8k_redwoodgreen.htm |
| 2020-03-06 | 8-K/A | 2019-07-25 | 2.01 Completion of Acquisition or Disposition of Assets | 2.01 On August 6, 2019 Redwood Green Corp. (“Redwood Green” or the “Company”) completed its previously announced acquisition of the cannabis brands and other assets of Critical Mass Industries LLC DBA Good Meds (“CMI”) for a total purchase price of approximately US $2 million and 13,553,233 shares of common stock (the “Acquisition”). | ea119339-8ka1_redwoodgreen.htm |
| 2020-03-06 | 8-K | 2020-03-03 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective as of March 3, 2020, Faun Chapin resigned as a director of Redwood Green Corp.. | ea119376-8k_redwoodgreen.htm |
| 2020-02-27 | 8-K | 2020-02-26 | 1.01 Entry into a Material Definitive Agreement; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 1.01 Entry into a Material Definitive Agreement. 5.02 Effective as of February 25, 2020, John Knapp resigned as a director of the Company. | ea119050-8k_redwoodgreen.htm |
| 2020-02-06 | 8-K | 2020-02-04 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On February 4, 2020, Redwood Green Corp. (the "Company") terminated Marcum LLP ("Marcum") as the Company's independent registered public accounting firm. | form8k.htm |
| 2019-12-20 | 8-K | 2019-12-20 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Dr. Delon Human has been appointed as Chairman of the Board of Directors, with immediate effect, on December 18, 2019. | form8k.htm |
| 2019-10-18 | 8-K | 2019-10-14 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year | 5.03 On September 18, 2019 our Board of Directors approved an agreement and plan of merger to merge with our wholly-owned subsidiary Good Meds USA, Inc. to effect the name change from First Columbia Development Corp. to Redwood Green Corp. Our company will remain the surviving company. | form8k.htm |
| 2019-09-23 | 8-K | 2019-09-19 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 On September 19, 2019, First Colombia Development Corp. (the “Company”) terminated Haynie & Company (“Haynie”) as the Company's independent registered public accounting firm. | form8k.htm |
| 2019-09-04 | 8-K | 2019-07-25 | 2.01 Completion of Acquisition or Disposition of Assets; 3.02 Unregistered Sales of Equity Securities; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 2.01 On August 6, 2019 First Colombia Development Corp. (the “Company”) completed its previously announced acquisition of the cannabis brands and other assets of Critical Mass Industries LLC DBA Good Meds ("Good Meds") for a total purchase price of approximately US $2 million and 13,553,233 shares of common stock. 3.02 On August 5, 2019 the Company closed a non-brokered private placement offering. 5.02 Joseph Graham has resigned as a member of the Board of Directors with immediate effect. 8.01 By virtue of the acquisition of Good Meds, the Company is providing an updated risk factor disclosure. | form8k.htm |
| 2019-07-17 | 8-K | 2019-07-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Mario Gobbo was appointed as a Director on July 8, 2019. | form8k.htm |
| 2019-07-01 | 8-K | 2019-06-21 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On June 21, 2019, Cindy Kelly tendered her resignation as Chief Financial Officer effective immediately. | form8k.htm |
| 2019-05-14 | 8-K | 2019-05-14 | 8.01 Other Events | 8.01 On May 14, 2019, the Registrant released a press release outlining the Registrant's proposed acquisition of various assets and businesses of Critical Mass, LLC dba Good Meds, its intellectual property from Good IPCO, and General Extract LLC. | form8k.htm |
| 2019-04-26 | 8-K | 2019-04-22 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 8.01 Other Events | 5.02 On April 23, 2019, Andres Fernandez Acosta, Chairman of the Board and a director of the Company tendered his resignation from both positions effective immediately. | form8k.htm |
| 2018-08-09 | 8-K | 2018-08-03 | 3.02 Unregistered Sales of Equity Securities | 3.02 On August 3, 2018, we completed the non-brokered private placement of 2,880,000 common shares at a purchase price of $0.25 per share for aggregate gross proceeds of $720,000. | form8k.htm |
| 2018-06-11 | 8-K | 2018-06-07 | 1.01 Entry into a Material Definitive Agreement | 1.01 Effective June 7, 2018, we executed a property purchase agreement with Terra Viva Property Development S.A.S. whereby we have agreed to acquire certain real property located in the Municipality of Tarso, Antioquia, in Colombia. | form8k.htm |
| 2018-05-18 | 8-K | 2018-05-10 | 1.01 Entry into a Material Definitive Agreement; 2.01 Completion of Acquisition or Disposition of Assets | 2.01 Effective May 10, 2018, we executed and closed a purchase agreement with Grupo Jaque Ltd. and First Colombia Devco SAS whereby we acquired the issued and outstanding share capital of First Colombia Devco SAS, a Colombian company, from its sole shareholder, Grupo Jaque Ltd. The consideration for the purchase was $100,000, which represented a reimbursement of the vendor’s costs to capitalize and establish the Colombian company, and the costs of establishing the company’s Colombian head offices.. | form8k.htm |
| 2018-05-09 | 8-K | 2018-05-08 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 On May 8, 2018, we appointed Andres Fernandez Acosta, Joseph Graham, Neil Kleinman and John Knapp as members of our board of directors. | form8k.htm |
| 2018-05-02 | 8-K | 2018-04-26 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 8.01 As previously disclosed, our board of directors approved an agreement and plan of merger to merge with our wholly-owned subsidiary First Colombia Development Corp., a Nevada corporation, to effect a name change from AFC Building Technologies Inc. to First Colombia Development Corp. Our company will remain the surviving company. | form8k.htm |
| 2018-04-13 | 8-K | 2018-03-06 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 8.01 On March 6, 2018, our board of directors approved an agreement and plan of merger to merge with our wholly-owned subsidiary First Colombia Development Corp., a Nevada corporation, to effect a name change from AFC Building Technologies Inc. to First Colombia Development Corp. Our company will remain the surviving company. | form8k.htm |
| 2018-03-02 | 8-K | 2018-02-22 | 3.02 Unregistered Sales of Equity Securities | 3.02 On February 22, 2018, we completed the non-brokered private placement of 2,000,000 common shares at a purchase price of $0.25 per share or $500,000 in the aggregate. | form8k.htm |
| 2018-02-15 | 8-K | 2018-02-14 | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | 5.02 Effective February 14, 2018, Cindy Lee Kelly resigned as director, president and CEO of our Company. | form8k.htm |
| 2016-11-03 | 8-K | 2016-11-03 | 4.01 Changes in Registrant's Certifying Accountant | 4.01 (i) On November 2, 2016, AFC Building Technologies Inc. (the “Company”) was advised by HJ and Associates LLC of their resignation as the Company’s independent registered public accounting firm. | form8k.htm |
| 2014-01-13 | 8-K | 2014-01-10 | 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Events | 5.03 In addition to the change of name, our board of directors and a majority holder of our company's voting securities approved a 1 old for 8 new forward split of our issued and outstanding shares of common stock. | form8k.htm |
| 2013-12-24 | 8-K | 2013-09-30 | 5.07 Submission of Matters to a Vote of Security Holders | 5.07 On December 19, 2013, we received written consent from our company’s board of directors and a holder of 67.87% of our company’s voting securities to effect a forward split of our issued and outstanding shares of common stock and to change the name of our company. | form8k.htm |